An Act to ensure affordable prescription medications through accountability standards

Bill H 4489 requires pharmaceutical manufacturers to disclose pricing information - including wholesale cost trends, research spending, and explanations for price changes - to a state commission. The commission reviews this data to assess whether drug pricing is unreasonable compared to a "proposed value" and then issues public recommendations, such as bulk purchasing programs or adjusted insurance costs, to improve affordability. Manufacturers face potential civil penalties of up to $500,000 for non-compliance or providing false information. The bill explicitly states its process does not affect individual patient treatment decisions or health plan coverage determinations.